|
Japan Continues to Dominate the Asia Pacific Pharma Market
By Shushmul Maheshwari
RNCOS E-Services Pvt. Ltd.
Email: press@rncos.com
http://www.rncos.com/
Monday - November 30, 2009
Category: Investment, Biotech, China Market
The Asia Pacific region has emerged as a new hub of pharmaceutical players in recent years. Rapid economic growth, increasing use of generics and changing regulatory environment in the Asia Pacific countries are certain key factors fuelling the growth of pharmaceutical markets in the region. In view of these factors, our new study "Asia Pacific Pharma Sector Analysis" says that the pharmaceutical market in the Asia Pacific region is forecast to grow at a CAGR of over 12% during 2010-2012.
Japan is the largest pharma market in the region and the second largest in the world. The country's pharma sector has registered a positive growth despite the economic recession. High affordability and increasing health insurance penetration can be considered as the two main growth drivers of pharma market in the country.
We have identified that generics will play an important role in the development of pharma markets in the region. Our research analyzes the market dynamics, drivers and resistors, and assesses the structure of generics markets in these countries. Besides this, the report also studies several emerging opportunities like contract manufacturing and medical tourism which are growing in line with the development of the pharmaceutical markets in these countries. Moreover, the report also highlights the regulatory environment in the country as it plays an important role in the development of the industry.
"Asia Pacific Pharma Sector Analysis" provides an in depth analysis of pharmaceutical markets in different countries of the Asia Pacific region. It gives an insight into the current market trends which are dominating pharma markets in the region. In addition to this, factors which are restraining th e growth of pharma markets have also been discussed in the report, which are followed by some key recommendations by our industry experts to overcome them, which would help clients in understanding the market dynamics in a better way.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM234.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Published at the www.InvestorIdeas.com Investing, Research and Industry Articles News Feed - Investorideas.com Financial Article Feed
Become an Investorideas.com Member and access some of our best investor research tools: Investing in Renewable Energy, Environment and Water Stocks
Become an Investorideas.com Member - Gain login access to 8 global stock directories including renewable energy stocks directory, environment stocks, water stocks, fuel cell stocks, biotech stocks, defense stocks, natural gas stocks, oil and gas stocks as well as the Insiders Corner investor newsletter covering insider buying trends on small cap stocks.
Investors: Sign up for free newsletter, stock and sector news alerts at Investorideas.com. Or publish your own stock picks and share your investing and trading ideas with other investors. Publish your investor ideas today!
www.InvestorIdeas.com - Big Ideas for the Small Cap Investor
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.
|
